$0.00030
-0.21-99.86%
al cierre: Feb 28, 4:00 PM EST

The average analyst price target for BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. is $30, 9999900.0% above the current price. The one analyst covering it rates it Buy. Targets range from $20 to $40. The latest change came on Mar 27, 2024, when Roth MKM raised its price target on BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. from $12 to $40 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months